Table 2 Results of multivariate Cox proportional-hazards analysis in testing set
Variable | For death | For progression-free survival | ||||
|---|---|---|---|---|---|---|
Hazard Ratio | 95% confidence interval | p | Hazard Ratio | 95% confidence interval | p | |
Age < 58.00 years (VS. ≥ 58 years) | 1.101 | 0.637 to 1.902 | 0.731 | 1.056 | 0.577 to 1.936 | 0.859 |
Gender Male (VS. Female) | 0.772 | 0.408 to 1.461 | 0.427 | 1.049 | 0.525 to 2.094 | 0.892 |
Clinical stage IV + III (VS. II +I) | 3.391 | 1.156 to 9.949 | 0.026 | 5.220 | 1.529 to 17.823 | 0.008 |
Tumor invasion T 4 + T 3 (VS. T 2 + T 1 ) | 1.066 | 0.320 to 3.553 | 0.917 | 0.730 | 0.206 to 2.585 | 0.626 |
Nodal stage N 3 + N 2 (VS. N 1 + N 0 ) | 0.705 | 0.387 to 1.282 | 0.251 | 0.735 | 0.373 to 1.448 | 0.373 |
Differentiation Low (VS. High) | 0.862 | 0.437 to 1.701 | 0.668 | 0.936 | 0.442 to 1.982 | 0.863 |
14-3-3σ Positive (VS. Negative) | 4.527 | 2.274 to 9.012 | 0.000 | 3.582 | 1.717 to 7.475 | 0.001 |